Anderson J P, Morrow J S
J Biol Chem. 1987 May 5;262(13):6365-72.
The functional significance of calmodulin binding to human erythrocyte spectrin has been investigated under native conditions. Both native calmodulin and calmodulin derivatized with the photoactivable cross-linker methyl 4-azidobenzimidate (azidocalmodulin) have been used. When azidocalmodulin is photolyzed in the presence of erythrocyte ghosts, ghost extracts, or purified protein, it cross-links predominately to the beta subunit of erythrocyte spectrin. This cross-linking is calcium-dependent, requires photolysis, and is inhibited by 100 microM trifluoperazine or unlabeled calmodulin. Calmodulin labeled spectrin exhibits a specific and non-calcium-dependent inhibition of its ability to bind actin, even in the presence of protein 4.1. Its ability to self-associate or to bind spectrin-depleted membrane vesicles is unperturbed. Native calmodulin also inhibits protein 4.1-stimulated spectrin-actin binding, but unlike that of covalently bound calmodulin, inhibition by the uncross-linked calmodulin requires calcium. The degree of inhibition of spectrin-actin-4.1 binding induced by native calmodulin is significant since 109 microM calmodulin inhibits over 63% of the spectrin-actin binding induced by 4.5 microM protein 4.1. These results demonstrate a specific effect of calmodulin on erythroid spectrin function and suggest that calmodulin may influence the binding of protein 4.1 and actin to spectrin within the cytoskeleton.
在天然条件下研究了钙调蛋白与人红细胞血影蛋白结合的功能意义。使用了天然钙调蛋白和用光活化交联剂4-叠氮基苯甲酸甲酯衍生化的钙调蛋白(叠氮钙调蛋白)。当叠氮钙调蛋白在红细胞血影、血影提取物或纯化蛋白存在下进行光解时,它主要与红细胞血影蛋白的β亚基交联。这种交联是钙依赖性的,需要光解,并且受到100微摩尔三氟拉嗪或未标记钙调蛋白的抑制。钙调蛋白标记的血影蛋白即使在存在蛋白4.1的情况下,也对其结合肌动蛋白的能力表现出特异性且非钙依赖性的抑制。其自身缔合或结合血影蛋白缺失的膜泡的能力不受影响。天然钙调蛋白也抑制蛋白4.1刺激的血影蛋白-肌动蛋白结合,但与共价结合的钙调蛋白不同,未交联的钙调蛋白的抑制作用需要钙。天然钙调蛋白诱导的血影蛋白-肌动蛋白-4.1结合的抑制程度是显著的,因为109微摩尔钙调蛋白抑制了4.5微摩尔蛋白4.1诱导的超过63%的血影蛋白-肌动蛋白结合。这些结果证明了钙调蛋白对红细胞血影蛋白功能的特异性作用,并表明钙调蛋白可能影响蛋白4.1和肌动蛋白与细胞骨架内血影蛋白的结合。